News
1don MSN
Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, ...
The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of ...
Me is now facing a multi-state lawsuit that seeks to block the genetic testing company from selling data without "explicit ...
Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results